BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29668751)

  • 21. Prognostic value of C-reactive protein in esophageal cancer: a meta-analysis.
    Zheng TL; Cao K; Liang C; Zhang K; Guo HZ; Li DP; Zhao S
    Asian Pac J Cancer Prev; 2014; 15(19):8075-81. PubMed ID: 25338987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.
    Schwameis R; Grimm C; Petru E; Natter C; Staudigl C; Lamm W; Koelbl H; Krainer M; Brodowicz T; Reinthaller A; Polterauer S
    PLoS One; 2015; 10(8):e0133838. PubMed ID: 26248232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis.
    Zhang Y; Ding C; Wang J; Sun G; Cao Y; Xu L; Zhou L; Chen X
    J Orthop Surg Res; 2015 Dec; 10():187. PubMed ID: 26697855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of programed death ligand 1 in patients with solid tumors: A meta-analysis.
    Jin Y; Zhao J; Shi X; Yu X
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C38-43. PubMed ID: 26323922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple stratification of survival using bone scan and serum C-reactive protein in prostate cancer patients with metastases.
    Nakashima J; Kikuchi E; Miyajima A; Nakagawa K; Oya M; Ohigashi T; Murai M
    Urol Int; 2008; 80(2):129-33. PubMed ID: 18362480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum C-reactive protein and overall survival of patients with osteosarcoma.
    Li X; Tian F; Wang F; Li Y
    Tumour Biol; 2015 Jul; 36(7):5663-6. PubMed ID: 25986475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Forkhead box F2 as a novel prognostic biomarker and potential therapeutic target in human cancers prone to bone metastasis: a meta-analysis.
    Chen Q; Zhou L; Chen F; Hu A; Wang K; Liang H; Dong J
    J Int Med Res; 2021 Apr; 49(4):3000605211002372. PubMed ID: 33845605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis.
    Zhou L; Cai X; Liu Q; Jian ZY; Li H; Wang KJ
    Sci Rep; 2015 Aug; 5():12733. PubMed ID: 26235332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
    Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
    BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-Reactive Protein as a New Prognostic Factor for Survival in Patients With Pancreatic Neuroendocrine Neoplasia.
    Wiese D; Kampe K; Waldmann J; Heverhagen AE; Bartsch DK; Fendrich V
    J Clin Endocrinol Metab; 2016 Mar; 101(3):937-44. PubMed ID: 26678655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis.
    Han Y; Mao F; Wu Y; Fu X; Zhu X; Zhou S; Zhang W; Sun Q; Zhao Y
    Int J Biol Markers; 2011; 26(4):209-15. PubMed ID: 22139643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of C-reactive protein to albumin ratio in patients with lung cancer.
    Deng TB; Zhang J; Zhou YZ; Li WM
    Medicine (Baltimore); 2018 Dec; 97(50):e13505. PubMed ID: 30558004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis.
    Liu ZQ; Chu L; Fang JM; Zhang X; Zhao HX; Chen YJ; Xu Q
    Asian J Androl; 2014; 16(3):467-71. PubMed ID: 24589465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High preoperative C-reactive protein values predict poor survival in patients on chronic hemodialysis undergoing nephrectomy for renal cancer.
    Omae K; Kondo T; Tanabe K
    Urol Oncol; 2015 Feb; 33(2):67.e9-13. PubMed ID: 25130069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
    Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
    Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pooled Analysis of C-Reactive Protein Levels and Mortality in Prostate Cancer Patients.
    Graff JN; Beer TM; Liu B; Sonpavde G; Taioli E
    Clin Genitourin Cancer; 2015 Aug; 13(4):e217-e221. PubMed ID: 25735198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.
    Tan Z; Shen W
    Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
    Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
    Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.